ATE482276T1 - Verfahren zur bestimmung der rezeptoraktivität und dafür verwendbare konstrukte - Google Patents
Verfahren zur bestimmung der rezeptoraktivität und dafür verwendbare konstrukteInfo
- Publication number
- ATE482276T1 ATE482276T1 AT04006057T AT04006057T ATE482276T1 AT E482276 T1 ATE482276 T1 AT E482276T1 AT 04006057 T AT04006057 T AT 04006057T AT 04006057 T AT04006057 T AT 04006057T AT E482276 T1 ATE482276 T1 AT E482276T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor activity
- methods
- gpcr
- activity
- usable therefor
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/869,568 US5891646A (en) | 1997-06-05 | 1997-06-05 | Methods of assaying receptor activity and constructs useful in such methods |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE482276T1 true ATE482276T1 (de) | 2010-10-15 |
Family
ID=25353824
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04006057T ATE482276T1 (de) | 1997-06-05 | 1998-06-04 | Verfahren zur bestimmung der rezeptoraktivität und dafür verwendbare konstrukte |
AT98925260T ATE262040T1 (de) | 1997-06-05 | 1998-06-04 | Methoden zur bestimmung der rezeptoraktivität und dafür verwendbare konstrukte |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98925260T ATE262040T1 (de) | 1997-06-05 | 1998-06-04 | Methoden zur bestimmung der rezeptoraktivität und dafür verwendbare konstrukte |
Country Status (10)
Country | Link |
---|---|
US (5) | US5891646A (de) |
EP (2) | EP1015608B1 (de) |
AT (2) | ATE482276T1 (de) |
AU (1) | AU759347B2 (de) |
CA (1) | CA2305810C (de) |
DE (3) | DE69822484T2 (de) |
DK (1) | DK1015608T3 (de) |
ES (1) | ES2182736T3 (de) |
PT (1) | PT1015608E (de) |
WO (1) | WO1998055635A1 (de) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5989835A (en) | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
US6759206B1 (en) | 1997-02-27 | 2004-07-06 | Cellomics, Inc. | System for cell-based screening |
US7853411B2 (en) * | 1997-02-27 | 2010-12-14 | Cellomics, Inc. | System for cell-based screening |
US6528271B1 (en) * | 1997-06-05 | 2003-03-04 | Duke University | Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |
US7541151B2 (en) * | 1997-06-05 | 2009-06-02 | Duke University | Single-cell biosensor for the measurement of GPCR ligands in a test sample |
US20050221280A1 (en) | 1998-02-02 | 2005-10-06 | Odyssey Thera, Inc. | Protein-protein interactions for pharmacological profiling |
JP2002507410A (ja) | 1998-03-27 | 2002-03-12 | プロルーム・リミテッド | ルシフェラーゼ、蛍光タンパク質、ルシフェラーゼおよび蛍光タンパク質をコードする核酸および、診断、高処理スクリーニングおよび新規アイテムにおけるその使用 |
US6692696B1 (en) | 1998-06-18 | 2004-02-17 | ARETé ASSOCIATES | Biosensor |
EP1092024A2 (de) * | 1998-06-30 | 2001-04-18 | Millennium Pharmaceuticals, Inc. | Rezeptor 14273, ein g-protein-gekoppelter rezeptor |
US6448005B1 (en) * | 1998-06-30 | 2002-09-10 | Millennium Pharmaceuticals, Inc. | 14723 Receptor, a novel G-protein coupled receptor |
US7534579B2 (en) * | 1998-06-30 | 2009-05-19 | Millennium Pharmaceuticals, Inc. | 14273 receptor, a novel G-protein coupled receptor |
WO2000014271A1 (en) * | 1998-09-03 | 2000-03-16 | Loma Linda University | METHOD FOR STUDYING PROTEIN INTERACTIONS $i(IN VIVO) |
USRE42190E1 (en) | 1998-11-20 | 2011-03-01 | Arena Pharmaceuticals, Inc. | Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors |
US7816492B2 (en) * | 1998-11-20 | 2010-10-19 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors |
US20030017528A1 (en) * | 1998-11-20 | 2003-01-23 | Ruoping Chen | Human orphan G protein-coupled receptors |
US6673554B1 (en) * | 1999-06-14 | 2004-01-06 | Trellie Bioinformatics, Inc. | Protein localization assays for toxicity and antidotes thereto |
CN1301726A (zh) * | 1999-12-27 | 2001-07-04 | 上海博德基因开发有限公司 | 一种新的多肽——视紫红质抑制蛋白家族11和编码这种多肽的多核苷酸 |
EP1257579B1 (de) * | 2000-02-04 | 2009-08-05 | Lexicon Pharmaceuticals, Inc. | Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide |
US6893827B1 (en) * | 2000-02-07 | 2005-05-17 | Applera Corporation | Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation |
JP2004500089A (ja) * | 2000-02-07 | 2004-01-08 | トロピックス・インコーポレーテッド | Gタンパク共役受容体の酵素アッセイ法 |
US7109315B2 (en) * | 2000-03-15 | 2006-09-19 | Bruce J. Bryan | Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
US7462457B2 (en) * | 2000-08-30 | 2008-12-09 | Johns Hopkins University School Of Medicine | Identification of activated receptors and ion channels |
WO2002035234A1 (en) * | 2000-10-26 | 2002-05-02 | The University Of British Columbia | A functional assay for g-protein-coupled receptors based on insect cells |
US7163800B2 (en) * | 2000-11-03 | 2007-01-16 | Molecular Devices Corporation | Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity |
US20050136431A1 (en) * | 2000-11-03 | 2005-06-23 | Oakley Robert H. | Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity |
US7018812B2 (en) * | 2000-11-03 | 2006-03-28 | Duke University | Modified G-protein coupled receptors |
WO2002046763A1 (en) * | 2000-12-04 | 2002-06-13 | Novo Nordisk A/S | Method of identifying compounds capable of acting as agonists or antagonists of g-protein coupled receptors |
US20020123071A1 (en) * | 2000-12-04 | 2002-09-05 | Knudsen Sanne Moller | Method of identifying compounds capable of acting as agonists or antagonists of G-protein coupled receptors |
US7279324B2 (en) * | 2001-01-23 | 2007-10-09 | Duke University | Nucleic acid encoding G-protein coupled receptor with modified DRY motif |
US7166699B2 (en) * | 2001-01-26 | 2007-01-23 | Vanderbilt University | Mosquito arrestin 1 polypeptides |
AU2002243912A1 (en) * | 2001-02-08 | 2002-09-12 | Temple University-Of The Commonwealth System Of Higher Education | Biosensor for detecting chemical agents |
US20030013137A1 (en) * | 2001-03-13 | 2003-01-16 | Barak Larry S. | Automated methods of detecting receptor activity |
CA2449649A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | A g-protein coupled receptor and uses therefor |
US20030119024A1 (en) * | 2001-07-20 | 2003-06-26 | Linsley Peter S. | Genes and proteins associated with T cell activation |
WO2003061594A2 (en) * | 2002-01-23 | 2003-07-31 | The Regents Of The University Of California | Methods and compositions for reducing the development of drug tolerance and/or physical dependence |
US20030182669A1 (en) * | 2002-03-19 | 2003-09-25 | Rockman Howard A. | Phosphoinositide 3-kinase mediated inhibition of GPCRs |
AU2003218586B2 (en) | 2002-04-12 | 2009-01-08 | Omeros Corporation | Method of identifying transmembrane protein-interacting compounds |
FR2851379B1 (fr) * | 2003-02-18 | 2008-02-01 | Cit Alcatel | Convertisseur en transfert direct d'energie |
DE60325719D1 (de) * | 2002-05-13 | 2009-02-26 | Molecular Devices Corp | Konstitutiv translozierende zelllinie |
US7290215B2 (en) * | 2002-06-03 | 2007-10-30 | Microsoft Corporation | Dynamic wizard interface system and method |
US7252953B2 (en) * | 2002-08-13 | 2007-08-07 | United States Of America Department Of Veterans Affairs | Method of detecting and preventing Alzheimer's disease, particularly at prodromal and early stages |
WO2004034054A2 (en) * | 2002-10-11 | 2004-04-22 | 7Tm Pharma A/S | Method for enhancing and prolonging the bioluminescence resonance energy transfer (bret) signal in a bret assay and a substrate solution for use in a bret assay |
EP1579212B1 (de) * | 2002-10-25 | 2008-12-31 | MDS Analytical Technologies (US) Inc. | Verfahren zur identifizierung von transmembranrezeptoragonisten mit reduzierter internalisierung |
US7615610B2 (en) * | 2003-01-24 | 2009-11-10 | Duke University | Modified trafficking patterns for arrestin and G-protein-coupled receptors via arrestin-ubiquitin chimera |
US7049076B2 (en) * | 2003-07-09 | 2006-05-23 | Sentigen Biosciences, Inc. | Method for assaying protein—protein interaction |
US20070224615A1 (en) * | 2003-07-09 | 2007-09-27 | Invitrogen Corporation | Methods for assaying protein-protein interactions |
US20070196865A1 (en) * | 2003-09-16 | 2007-08-23 | Molecular Devices Corporation | Methods Of Screening Compositions For G Protein-Coupled Receptors Aganist Agonists |
US7488583B2 (en) * | 2003-09-25 | 2009-02-10 | Odyssey Thera, Inc. | Fragment complementation assays for G-protein-coupled receptors and their signaling pathways |
ATE444489T1 (de) * | 2003-10-17 | 2009-10-15 | Tata Inst Of Fundamental Res | Neuer test zum screening von antipsychotika |
US20060292559A1 (en) * | 2005-06-23 | 2006-12-28 | Beckman Coulter, Inc. | Cell-based microarrays, and methods for their preparation and use |
WO2007008942A2 (en) * | 2005-07-11 | 2007-01-18 | Aerie Pharmaceuticals, Inc. | Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases |
US7470787B2 (en) * | 2005-07-11 | 2008-12-30 | Aerie Pharmaceuticals, Inc. | Isoquinoline compounds |
US7763437B1 (en) * | 2005-07-15 | 2010-07-27 | Duke University | Methods for identifying compounds that regulate β-Arrestin signaling complexes |
WO2007092938A2 (en) * | 2006-02-08 | 2007-08-16 | Invitrogen Corporation | Cellular assays for signaling receptors |
ATE528647T1 (de) | 2006-03-16 | 2011-10-15 | Life Technologies Corp | Verfahren zur untersuchung von protein-protein- interaktionen |
CA2664335C (en) | 2006-09-20 | 2014-12-02 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
AU2007317204A1 (en) * | 2006-11-10 | 2008-05-15 | Dimerix Bioscience Pty Ltd | Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
AU2007336242B2 (en) | 2006-12-19 | 2012-08-30 | Ablynx N.V. | Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
US8455513B2 (en) * | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
JP2010529127A (ja) | 2007-06-05 | 2010-08-26 | イエール ユニバーシティ | 受容体型チロシンキナーゼの阻害物質およびその使用方法 |
US8666671B2 (en) * | 2007-07-05 | 2014-03-04 | Enhanced Pharmaceuticals, Inc. | Method for determining drug-molecular combinations that modulate and enhance the therapeutic safety and efficacy of biological or pharmaceutical drugs |
KR101636306B1 (ko) * | 2007-09-04 | 2016-07-05 | 사노피 | 프로테아제 활성화된 리포터를 사용한 단백질-단백질 상호작용 조절 분자의 확인 방법 |
US8455514B2 (en) * | 2008-01-17 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-and 7-amino isoquinoline compounds and methods for making and using the same |
JP5259207B2 (ja) * | 2008-02-05 | 2013-08-07 | オリンパス株式会社 | 細胞画像解析装置及びその方法並びにそのソフトウェア |
US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
FR2934684B1 (fr) | 2008-07-31 | 2012-11-16 | Cis Bio Int | Methode de detection de l'internalisation de proteines membranaires. |
GB0817861D0 (en) * | 2008-09-30 | 2008-11-05 | Ge Healthcare Uk Ltd | Methods and compounds for testing binding of a ligand to a g protein-coupled receptor |
WO2010075540A1 (en) * | 2008-12-23 | 2010-07-01 | Burnham Institute For Medical Research | Methods and compositions for synaphically-targeted treatment for cancer |
GB0905419D0 (en) | 2009-03-30 | 2009-05-13 | Ge Healthcare Uk Ltd | Methods for testing ligand binding to G protein-coupled receptors |
ES2553827T3 (es) | 2009-05-01 | 2015-12-14 | Aerie Pharmaceuticals, Inc. | Inhibidores de mecanismo doble para el tratamiento de enfermedad |
US8795977B2 (en) * | 2009-12-02 | 2014-08-05 | Conopco, Inc. | Method for screening a potential modulator compound of a taste receptor |
CA2821985C (en) | 2011-01-11 | 2019-07-09 | Dimerix Bioscience Pty Ltd | Combination therapy |
US9626650B2 (en) | 2011-04-14 | 2017-04-18 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US10445846B2 (en) | 2011-04-14 | 2019-10-15 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
EP2742350B1 (de) | 2011-08-08 | 2019-10-30 | The Coca-Cola Company | Zelllinien mit endogenen geschmacksrezptoren und deren verwendungen |
US8514067B2 (en) | 2011-08-16 | 2013-08-20 | Elwha Llc | Systematic distillation of status data relating to regimen compliance |
BR112015010620A2 (pt) | 2012-11-08 | 2017-07-11 | Pfizer | compostos heteroaromáticos e seus usos como ligantes de dopamina d1 |
CN109528721B (zh) | 2013-03-15 | 2021-10-01 | 爱瑞制药公司 | 联合治疗 |
US9914760B2 (en) | 2013-06-29 | 2018-03-13 | Firmenich Sa | Methods of identifying, isolating and using odorant and aroma receptors |
WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
JP6832946B2 (ja) | 2015-11-17 | 2021-02-24 | アエリエ ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤およびその中間体の調製方法 |
US9643927B1 (en) | 2015-11-17 | 2017-05-09 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
EP3506890A1 (de) | 2016-08-31 | 2019-07-10 | Aerie Pharmaceuticals, Inc. | Ophthalmische zusammensetzungen |
SG11201908179UA (en) | 2017-03-31 | 2019-10-30 | Aerie Pharmaceuticals Inc | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
WO2020056345A1 (en) | 2018-09-14 | 2020-03-19 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
Family Cites Families (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US31006A (en) * | 1861-01-01 | Feeding mechanism for spoke-machines | ||
US36547A (en) * | 1862-09-23 | Improvement in locks | ||
US3654090A (en) | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
USRE31006E (en) * | 1968-09-24 | 1982-08-03 | Akzona Incorporated | Process for the demonstration and determination of reaction components having specific binding affinity for each other |
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
US4219335A (en) | 1978-09-18 | 1980-08-26 | E. I. Du Pont De Nemours And Company | Immunochemical testing using tagged reagents |
US4491632A (en) | 1979-10-22 | 1985-01-01 | The Massachusetts General Hospital | Process for producing antibodies to hepatitis virus and cell lines therefor |
US4444887A (en) | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
EP0043718B1 (de) | 1980-07-07 | 1984-11-28 | National Research Development Corporation | Zellinien |
US4341761A (en) | 1980-07-25 | 1982-07-27 | E. I. Du Pont De Nemours And Company | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon |
US4324633A (en) | 1980-10-20 | 1982-04-13 | Lovejoy Curtis N | Electrolytic apparatus for treating continuous strip material |
US4466917A (en) | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
US4493890A (en) | 1981-03-23 | 1985-01-15 | Miles Laboratories, Inc. | Activated apoglucose oxidase and its use in specific binding assays |
US4451570A (en) | 1981-03-26 | 1984-05-29 | The Regents Of The University Of California | Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line |
US4426330A (en) | 1981-07-20 | 1984-01-17 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
US4534899A (en) | 1981-07-20 | 1985-08-13 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
US4399121A (en) | 1981-11-04 | 1983-08-16 | Miles Laboratories, Inc. | Iodothyronine immunogens and antibodies |
US4427783A (en) | 1981-12-14 | 1984-01-24 | Hoffmann-La Roche Inc. | Immunoassay of thymosin α1 |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5972629A (en) | 1984-08-17 | 1999-10-26 | The Scripps Research Institute | Method for characterizing antigenic reactivity of biological sample |
US4493795A (en) | 1983-10-17 | 1985-01-15 | Syntex (U.S.A.) Inc. | Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
US5583024A (en) | 1985-12-02 | 1996-12-10 | The Regents Of The University Of California | Recombinant expression of Coleoptera luciferase |
US4908773A (en) | 1987-04-06 | 1990-03-13 | Genex Corporation | Computer designed stabilized proteins and method for producing same |
US4981784A (en) | 1987-12-02 | 1991-01-01 | The Salk Institute For Biological Studies | Retinoic acid receptor method |
AU5154390A (en) | 1989-02-15 | 1990-09-05 | Microtek Medical, Inc. | Biocompatible material and prosthesis |
US5080924A (en) | 1989-04-24 | 1992-01-14 | Drexel University | Method of making biocompatible, surface modified materials |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5284746A (en) * | 1990-02-08 | 1994-02-08 | Zymogenetics, Inc. | Methods of producing hybrid G protein-coupled receptors |
US5665710A (en) | 1990-04-30 | 1997-09-09 | Georgetown University | Method of making liposomal oligodeoxynucleotide compositions |
US5462856A (en) | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
ATE199391T1 (de) * | 1990-09-13 | 2001-03-15 | Univ Duke | Expression von an g-protein gekoppelten rezeptoren in hefe |
US5569824A (en) | 1991-01-04 | 1996-10-29 | Baylor College Of Medicine | Transgenic mice containing a disrupted p53 gene |
JP3220180B2 (ja) | 1991-05-23 | 2001-10-22 | 三菱化学株式会社 | 薬剤含有タンパク質結合リポソーム |
US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
WO1993003382A2 (en) * | 1991-08-01 | 1993-02-18 | Pharmaceutical Discovery Corporation | Characterization of specific drug receptors with fluorescent ligands |
US5576436A (en) * | 1991-08-01 | 1996-11-19 | Pharmaceutical Discovery Corporation | Fluorescent ligands |
JPH06511386A (ja) * | 1991-10-01 | 1994-12-22 | アメリカ合衆国 | リガンドおよびリガンドのアンタゴニストを同定する方法 |
CA2054602C (en) | 1991-10-31 | 2003-04-22 | Anthony Pawson | Method for assaying for a substance that affects an sh2-phosphorylated ligand regulatory system |
US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
DE4138621A1 (de) | 1991-11-25 | 1993-06-17 | Boehringer Ingelheim Int | Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg |
US5670113A (en) | 1991-12-20 | 1997-09-23 | Sibia Neurosciences, Inc. | Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same |
USRE36547E (en) | 1992-09-21 | 2000-02-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
US6096756A (en) | 1992-09-21 | 2000-08-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
US5597699A (en) | 1992-09-30 | 1997-01-28 | Lanzara; Richard G. | Method for determining drug compositions to prevent desensitization of cellular receptors |
US5366889A (en) * | 1992-11-30 | 1994-11-22 | The General Hospital Corporation | DNA encoding a protein-coupled receptor kinase |
US5360728A (en) | 1992-12-01 | 1994-11-01 | Woods Hole Oceanographic Institution (W.H.O.I.) | Modified apoaequorin having increased bioluminescent activity |
WO1994016684A1 (en) * | 1993-01-26 | 1994-08-04 | The Johns Hopkins University | INHIBITION OF βARK AND β-ARRESTIN |
US6103492A (en) | 1993-03-08 | 2000-08-15 | Indiana University | Polynucleotide encoding mu opioid receptor |
US6100042A (en) | 1993-03-31 | 2000-08-08 | Cadus Pharmaceutical Corporation | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
US5328687A (en) | 1993-03-31 | 1994-07-12 | Tri-Point Medical L.P. | Biocompatible monomer and polymer compositions |
US6255059B1 (en) | 1993-03-31 | 2001-07-03 | Cadus Pharmaceutical Corporation | Methods for identifying G protein coupled receptor effectors |
US5912122A (en) | 1993-06-04 | 1999-06-15 | Sibia Neurosciences, Inc. | Nucleic acids encoding and method for detecting nucleic acid encoding human metabotropic glutamate receptor subtype mGluR6 |
US6007986A (en) | 1993-06-23 | 1999-12-28 | The Regents Of The University Of California | Methods for anti-addictive narcotic analgesic activity screening |
US5882944A (en) | 1993-06-23 | 1999-03-16 | The Regents Of The University Of California | Methods for G protein coupled receptor activity screening |
US5491084A (en) * | 1993-09-10 | 1996-02-13 | The Trustees Of Columbia University In The City Of New York | Uses of green-fluorescent protein |
US5532151A (en) | 1993-09-17 | 1996-07-02 | Icos Corporation | G protein-coupled receptor kinase GRK6 |
US5658783A (en) | 1993-11-08 | 1997-08-19 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Mammalian methadone-specific opioid receptor gene and uses |
AU1297995A (en) | 1993-11-26 | 1995-06-13 | Lawrence B Hendry | Design of drugs involving receptor-ligand-dna interactions |
WO1995021191A1 (en) | 1994-02-04 | 1995-08-10 | William Ward | Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein |
GB9403600D0 (en) | 1994-02-24 | 1994-04-13 | Univ Glasgow | Three dimensional hormone structure |
AU1812595A (en) | 1994-02-28 | 1995-09-11 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Cell lines for the identification of substances affecting insulin receptor mediated signal transduction |
US5627039A (en) | 1994-03-18 | 1997-05-06 | Baylor College Of Medicine | Mortalin and methods for determining complementation group assignment of cancer cells |
US5569827A (en) | 1994-06-06 | 1996-10-29 | Universite De Montreal | Transgenic mouse for the neuronal expression of HIV gp160 |
US5750566A (en) | 1994-08-12 | 1998-05-12 | Eli Lilly And Company | Synthetic excitatory amino acids |
US5463564A (en) | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
US5625048A (en) | 1994-11-10 | 1997-04-29 | The Regents Of The University Of California | Modified green fluorescent proteins |
US5777079A (en) | 1994-11-10 | 1998-07-07 | The Regents Of The University Of California | Modified green fluorescent proteins |
US5744313A (en) | 1994-12-09 | 1998-04-28 | The Regents Of The University Of California | Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
US5958713A (en) | 1995-01-31 | 1999-09-28 | Novo Nordisk A/S | Method of detecting biologically active substances by using green fluorescent protein |
ATE211506T1 (de) | 1995-01-31 | 2002-01-15 | Bioimage As | Ein verfahren zum nachweis biologisch aktiver substanzen |
WO1996027027A1 (en) | 1995-03-02 | 1996-09-06 | Rutgers The State University Of New Jersey | Improved method for purifying green fluorescent protein |
GB9504446D0 (en) | 1995-03-06 | 1995-04-26 | Medical Res Council | Improvements in or relating to gene expression |
US6017496A (en) | 1995-06-07 | 2000-01-25 | Irori | Matrices with memories and uses thereof |
US6025129A (en) | 1995-04-25 | 2000-02-15 | Irori | Remotely programmable matrices with memories and uses thereof |
US6100026A (en) | 1995-04-25 | 2000-08-08 | Irori | Matrices with memories and uses thereof |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5767337A (en) | 1995-07-31 | 1998-06-16 | Duke University | Creation of human apolipoprotein E isoform specific transgenic mice in apolipoprotein deficient "knockout" mice |
JPH11171896A (ja) | 1995-09-19 | 1999-06-29 | Kirin Brewery Co Ltd | 新規ペプチド化合物およびその医薬組成物 |
US5770176A (en) | 1995-12-08 | 1998-06-23 | Chiron Diagnostics Corporation | Assays for functional nuclear receptors |
US5874304A (en) | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
US6027890A (en) | 1996-01-23 | 2000-02-22 | Rapigene, Inc. | Methods and compositions for enhancing sensitivity in the analysis of biological-based assays |
US5804387A (en) | 1996-02-01 | 1998-09-08 | The Board Of Trustees Of The Leland Stanford Junior University | FACS-optimized mutants of the green fluorescent protein (GFP) |
US5989835A (en) * | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
US5912137A (en) | 1996-07-16 | 1999-06-15 | The Regents Of The University Of California | Assays for protein kinases using fluorescent |
US5912138A (en) | 1996-07-25 | 1999-06-15 | Cold Spring Harbor Laboratory | Substrate trapping protein tyrosine phosphatases |
US5804436A (en) | 1996-08-02 | 1998-09-08 | Axiom Biotechnologies, Inc. | Apparatus and method for real-time measurement of cellular response |
US5874268A (en) * | 1996-09-23 | 1999-02-23 | Duke University | Method of introducing exogenous compounds into cells by electroporation and apparatus for same |
US6087115A (en) | 1997-01-22 | 2000-07-11 | Cornell Research Foundation, Inc. | Methods of identifying negative antagonists for G protein coupled receptors |
US5998204A (en) | 1997-03-14 | 1999-12-07 | The Regents Of The University Of California | Fluorescent protein sensors for detection of analytes |
US5882067A (en) * | 1997-06-09 | 1999-03-16 | Sunrise Medical Hhg Inc. | Rigid seat for folding invalid walker |
US5972639A (en) | 1997-07-24 | 1999-10-26 | Irori | Fluorescence-based assays for measuring cell proliferation |
US5987390A (en) | 1997-10-28 | 1999-11-16 | Smithkline Beecham Corporation | Methods and systems for identification of protein classes |
ES2156845T1 (es) | 1998-04-14 | 2001-08-01 | Arena Pharm Inc | Receptores de serotonina humana no endogenos constitutivamente activados y moduladores de moleculas pequeñas para estos. |
US6140509A (en) | 1998-06-26 | 2000-10-31 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
US6438235B2 (en) * | 1998-08-05 | 2002-08-20 | Hewlett-Packard Company | Media content protection utilizing public key cryptography |
US6150393A (en) | 1998-12-18 | 2000-11-21 | Arena Pharmaceuticals, Inc. | Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors |
US6463534B1 (en) * | 1999-03-26 | 2002-10-08 | Motorola, Inc. | Secure wireless electronic-commerce system with wireless network domain |
US7073063B2 (en) * | 1999-03-27 | 2006-07-04 | Microsoft Corporation | Binding a digital license to a portable device or the like in a digital rights management (DRM) system and checking out/checking in the digital license to/from the portable device or the like |
US6697944B1 (en) * | 1999-10-01 | 2004-02-24 | Microsoft Corporation | Digital content distribution, transmission and protection system and method, and portable device for use therewith |
CN1239800C (zh) * | 1999-11-30 | 2006-02-01 | 博丁数字有限公司 | 电子钥匙装置、管理电子钥匙信息的系统和方法 |
US6915425B2 (en) * | 2000-12-13 | 2005-07-05 | Aladdin Knowledge Systems, Ltd. | System for permitting off-line playback of digital content, and for managing content rights |
US6975202B1 (en) * | 2000-11-21 | 2005-12-13 | International Business Machines Corporation | Electronic key system, apparatus and method |
-
1997
- 1997-06-05 US US08/869,568 patent/US5891646A/en not_active Expired - Lifetime
-
1998
- 1998-06-04 ES ES98925260T patent/ES2182736T3/es not_active Expired - Lifetime
- 1998-06-04 DE DE1998622484 patent/DE69822484T2/de not_active Expired - Lifetime
- 1998-06-04 EP EP98925260A patent/EP1015608B1/de not_active Expired - Lifetime
- 1998-06-04 DE DE1015608T patent/DE1015608T1/de active Pending
- 1998-06-04 PT PT98925260T patent/PT1015608E/pt unknown
- 1998-06-04 AU AU77255/98A patent/AU759347B2/en not_active Ceased
- 1998-06-04 DK DK98925260T patent/DK1015608T3/da active
- 1998-06-04 EP EP04006057A patent/EP1441032B1/de not_active Expired - Lifetime
- 1998-06-04 AT AT04006057T patent/ATE482276T1/de not_active IP Right Cessation
- 1998-06-04 DE DE69841908T patent/DE69841908D1/de not_active Expired - Lifetime
- 1998-06-04 CA CA002305810A patent/CA2305810C/en not_active Expired - Lifetime
- 1998-06-04 WO PCT/US1998/011628 patent/WO1998055635A1/en active IP Right Grant
- 1998-06-04 AT AT98925260T patent/ATE262040T1/de not_active IP Right Cessation
-
1999
- 1999-01-20 US US09/233,530 patent/US6110693A/en not_active Expired - Lifetime
-
2002
- 2002-05-09 US US10/141,725 patent/US7138240B2/en not_active Expired - Lifetime
-
2003
- 2003-07-29 US US10/628,909 patent/US20040101887A1/en not_active Abandoned
-
2007
- 2007-10-19 US US11/875,581 patent/US20080261256A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69841908D1 (de) | 2010-11-04 |
CA2305810C (en) | 2007-11-20 |
AU759347B2 (en) | 2003-04-10 |
EP1015608A1 (de) | 2000-07-05 |
US20080261256A1 (en) | 2008-10-23 |
CA2305810A1 (en) | 1998-12-10 |
DE69822484D1 (de) | 2004-04-22 |
AU7725598A (en) | 1998-12-21 |
US7138240B2 (en) | 2006-11-21 |
US6110693A (en) | 2000-08-29 |
EP1441032A1 (de) | 2004-07-28 |
US5891646A (en) | 1999-04-06 |
ES2182736T3 (es) | 2004-09-01 |
WO1998055635A1 (en) | 1998-12-10 |
DE1015608T1 (de) | 2002-11-14 |
WO1998055635A9 (en) | 2003-05-08 |
US20060188944A1 (en) | 2006-08-24 |
DK1015608T3 (da) | 2004-06-01 |
EP1015608B1 (de) | 2004-03-17 |
ATE262040T1 (de) | 2004-04-15 |
ES2182736T1 (es) | 2003-03-16 |
PT1015608E (pt) | 2004-07-30 |
EP1441032B1 (de) | 2010-09-22 |
DE69822484T2 (de) | 2005-01-13 |
US20040101887A1 (en) | 2004-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69841908D1 (de) | Verfahren zur Bestimmung der Rezeptoraktivität und dafür verwendbare Konstrukte | |
ATE246361T1 (de) | Verfahren zur bestimmung von ige | |
IL120082A0 (en) | Method for determining the amount of an amylin receptor binding compound in a sample | |
ATE113722T1 (de) | Vorrichtung und verfahren zur bestimmung einer komponente einer probe. | |
DE69936453D1 (de) | Für einen g-protein gekoppelten rezeptor, der an der empfindungstransduktion beteiligt ist, kodierende nukleinsäuren | |
DK0608370T3 (da) | Bindingsassay med anvendelse af mærket reagens | |
ZA846439B (en) | Polypeptide-induced monoclonal receptors to protein ligands | |
DE69941688D1 (de) | Immunoassays unter verwendung von sers (surface enhanced raman scattering) | |
ATE308609T1 (de) | Pth rezeptor und testverfahren unter verwendung desselben | |
DE69837811D1 (de) | Menschlicher lysophosphatidsäure rezeptor und dessen verwendung | |
HK1021229A1 (en) | A in vitro method of determining the presence of aprotein in an isolated biological sample. | |
ATE462975T1 (de) | Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers | |
EP1257818A4 (de) | Auf enzymen basierender assay für g-protein-gekoppelte rezeptoren | |
ATE488589T1 (de) | Transkriptionaler intermediärfaktor 2 | |
WO2004087622A3 (en) | Gpr54 receptor agonist and antagonist useful for the treatmentt of gonadotropin related diseases | |
DE69825583D1 (de) | Methode zum bestimmen der aktivierung von zytokinrezeptoren mit hilfe eines antikörpers | |
DE69926624D1 (de) | Verfahren zum screenen einer die oligomerisierung von rezeptorproteinmolekülen fördernden substanz | |
DE60216482D1 (de) | Zusammensetzungen und verfahren zum bestimmen von aa4rp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |